weight loss plateau tirzepatide Plateau: 9 Reasons Progress Slows The Turtle Diaries The Plateau

4 webinar, New Weight Loss Drugs Raise Issues of Coverage, Cost, Access and Equity, for which the recording is posted here.

Almost 50% of people taking GLP-1 medication think it's okay to ask someone about their use of weight-loss medication, but only in certain situations, such as: Close personal relationships: 64% Concern for health: 62% Professional/healthcare settings: 60% If they have posted about their weight loss journey online: 40% 3 in 4 people taking GLP-1 medication are transparent about their weight-loss medication use

Advancing this field requires overcoming several key challenges: The lack of reliable biomarkers for predicting treatment response and enabling precise patient stratification

Common side effects of Ozempic may include nausea, vomiting, and headache

Am Health Drug Benefits 10(4):178188 Aroda VR (2018) A review of GLP-1 receptor agonists: evolution and advancement, through the lens of randomised controlled trials